NACDS President and CEO Steven C. Anderson issued the following statement, upon the release of a U.S. Department of Health and Human Services (HHS) Fact Sheet describing decision-making underway about implications of the May 11, 2023, expiration of the current Public Health Emergency (PHE).
“NACDS 2023” continues a bold approach to advancing NACDS members’ “total store, total person” health and wellness vision.
While we all want to move on from COVID-19, doing so should not mean leaving behind millions of Americans who have relied on their trusted, local pharmacies for testing, vaccinations, and care during the pandemic.
The 2023 NACDS Regional Chain Conference continued today with more presentations from top speakers on the most timely issues affecting the industry and the patients and consumers it serves.
With the U.S. House of Representatives slated to consider legislation related to the pandemic this week, NACDS has an important message: constituents view the importance of pharmacy access as a lesson that must be learned from the past three years.
A White House ceremony on Tuesday marked the end of the “X-waiver” requirement.
NACDS’ engagement leverages bipartisan momentum for pro-patient, pro-pharmacy PBM reform at state and federal levels.
Ben Pearlman, Esq., has joined the staff of the National Association of Chain Drug Stores (NACDS). He fills the role of director of state government affairs. Most recently, Ben served as senior director of government and public affairs for Shipt, Inc.
NACDS: Floridians, all Americans deserve better than the current “pharmaceutical benefit manipulation”
Texans rank pharmacies as most accessible healthcare destination tested, and support policies that would continue to allow patient choice when it comes to accessing services.
